Lei L, Huang Y, Shi L, Ye W, et al. Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-alpha via SNHG17/Hippo-YAP axis. Breast Cancer Res Treat 2023 Nov 4. doi: 10.1007/s10549-023-07138.
PMID: 37924380